Skip to NavigationSkip to content

Contract research news in brief

Published on 26/11/10 at 09:12am

Our round-up of recent development in the contract research sector includes updates from Selcia, Iris Pharma, ICON, Proteome Sciences, Chiltern, PRA, Chemir and Cyanta.

Medicinal chemistry services company Selcia Ltd says it will work with UK firm Convergence Pharmaceuticals on the development of novel and high value analgesic medicines for chronic pain. Led by UK industry stalwart Dr Clive Dix, Convergence was set up in October to develop a series of neuroscience compounds divested by GlaxoSmithKline.

French contract research organisation Iris Pharma has been awarded the High Performance Prize by national newspaper Les Echos in recognition of its recent strong growth. Iris Pharma specialises in preclinical research and clinical trials in ophthalmology and in 2011 is planning to open new subsidiaries in Spain, Italy and Germany.

Ireland's ICON plc has forged a strategic alliance with fellow CRO Proteome Sciences to offer their combined expertise in the development and provision of biomarkers used in the development of new medicines. In a statement, ICON said the collaboration will allow it to bolster its offering with "an integrated suite of labeling, separation and mass spectrometry technologies for protein and peptide profiling in complex biological materials".

Chiltern International has launched a new electronic Trial Master File (TMF) management system - dubbed Chiltern SAFE - which it claims "saves administrative time and increases accuracy and security of records handling" for clinical trial organisers. The system can be bought as a standalone product or bundled with Chiltern's other clinical trial service packages.

PRA International has opened a new laboratory facility in the US which will offer bioanalytical services for local, national, and international clinical trials. The new unit will complement PRA's other bioanalytical facility in the Netherlands. "For the first time in the US, PRA's full suite of early clinical development and bioanalytical services is now available in one locale," commented Peter Ketelaar, the CRO's vice president of bioanalytical laboratories.

Chemir Analytical Services has reabsorbed Cyanta, a company which it spun out in 2007, saying the two companies will serve their customers better as a combined entity. Cyanta offers pharmaceutical product development support, including analytical method development and validation, bioanalytical support, custom synthesis, as well as physical and chemical testing for medical devices. Chemir specialises in chemical analysis and materials testing.

Phil Taylor

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches